⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10828045 | 0.80 | — | — | |
| SCHEMBL14707175 | 0.78 | MEN1 (0.42) | — | |
| SCHEMBL10373754 | 0.77 | LMNA (0.39) | — | |
| SCHEMBL12446699 | 0.76 | — | — | |
| SCHEMBL2099259 | 0.76 | — | — | |
| SCHEMBL3328956 | 0.76 | — | — | |
| SCHEMBL2105848 | 0.75 | — | — | |
| SCHEMBL24477517 | 0.75 | CHRNB2 (0.38) | — | |
| SCHEMBL7153467 | 0.75 | — | — | |
| SCHEMBL20954105 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4065549-B1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORP (CA) | 2026-03-11 | — | — | EP | disclosed |
| US-12325709-B2 | Cannabinoid derivatives | CANOPY GROWTH CORPORATION (CA) | 2025-06-10 | — | — | US | disclosed |
| US-20230286906-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2023-09-14 | — | — | US | disclosed |
| US-20230286906-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2023-09-14 | — | — | US | disclosed |
| US-20230286906-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2023-09-14 | — | — | US | disclosed |
| US-20230059582-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2023-02-23 | — | — | US | disclosed |
| US-20230059582-A1 | CANNABINOID DERIVATIVES | CANOPY GROWTH CORPORATION (CA) | 2023-02-23 | — | — | US | disclosed |
| US-20220348586-A1 | CANNABINOID DERIVATIVES | JGB COLLATERAL LLC | 2022-11-03 | — | — | US | disclosed |
| EP-4073033-A1 | CANNABINOID DERIVATIVES | Canopy Growth Corporation (CA) | 2022-10-19 | — | — | EP | disclosed |
| EP-4065549-A1 | CANNABINOID DERIVATIVES | Canopy Growth Corporation (CA) | 2022-10-05 | — | — | EP | disclosed |
| US-5977089-A | ORALLY ADMINISTERING TENOFOVIR DERIVATIVES | GILEAD SCIENCES, INC. (US) | 1999-11-02 | — | — | US | disclosed |
| US-5922695-A | COMPOUNDS CONTAINING CARBONATE OR CARBAMATE GROUPS | GILEAD SCIENCES, INC. (US) | 1999-07-13 | — | — | US | disclosed |
| EP-0915894-A1 | NUCLEOTIDE ANALOGS | GILEAD SCIENCES, INC. (US) | 1999-05-19 | — | — | EP | disclosed |
| WO-1998004569-A1 | NUCLEOTIDE ANALOGS | GILEAD SCIENCES, INC. (US) | 1998-02-05 | — | — | WO | disclosed |
| US-5310736-A | Pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 1994-05-10 | — | — | US | disclosed |
| US-5210197-A | 2-Cyano-2-alkoximino-N-heterocyclylmethylacetamides | BAYER AKTIENGESELLSCHAFT (DE) | 1993-05-11 | — | — | US | disclosed |
| EP-0428928-A2 | Substituted aminals | BAYER AG (DE) | 1991-05-29 | — | — | EP | disclosed |
| EP-0201166-B1 | ERYTHROMYCIN DERIVATIVES | BEECHAM GROUP PLC (GB) | 1990-02-07 | — | — | EP | disclosed |
| US-4847242-A | ANTIBIOTICS | BEECHAM GROUP P.L.C. (GB) | 1989-07-11 | — | — | US | disclosed |
| EP-0201166-A1 | Erythromycin derivatives | BEECHAM GROUP PLC (GB) | 1986-11-12 | — | — | EP | disclosed |